Hong Kong · Delayed Price · Currency is HKD Essex Bio-Technology Statistics
Total Valuation
HKG:1061 has a market cap or net worth of HKD 2.51 billion. The enterprise value is 2.16 billion.
| Market Cap | 2.51B |
| Enterprise Value | 2.16B |
Important Dates
The next estimated earnings date is Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | Sep 8, 2025 |
Share Statistics
HKG:1061 has 567.01 million shares outstanding. The number of shares has decreased by -4.11% in one year.
| Current Share Class | 567.01M |
| Shares Outstanding | 567.01M |
| Shares Change (YoY) | -4.11% |
| Shares Change (QoQ) | -0.81% |
| Owned by Insiders (%) | 54.08% |
| Owned by Institutions (%) | 1.64% |
| Float | 260.38M |
Valuation Ratios
The trailing PE ratio is 8.04 and the forward PE ratio is 7.77.
| PE Ratio | 8.04 |
| Forward PE | 7.77 |
| PS Ratio | 1.46 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.96 |
| P/FCF Ratio | 9.91 |
| P/OCF Ratio | 6.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.94, with an EV/FCF ratio of 8.52.
| EV / Earnings | 6.90 |
| EV / Sales | 1.26 |
| EV / EBITDA | 4.94 |
| EV / EBIT | 5.58 |
| EV / FCF | 8.52 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.90 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.66 |
| Debt / FCF | 1.15 |
| Interest Coverage | 71.31 |
Financial Efficiency
Return on equity (ROE) is 14.60% and return on invested capital (ROIC) is 16.58%.
| Return on Equity (ROE) | 14.60% |
| Return on Assets (ROA) | 7.83% |
| Return on Invested Capital (ROIC) | 16.58% |
| Return on Capital Employed (ROCE) | 15.68% |
| Weighted Average Cost of Capital (WACC) | 3.39% |
| Revenue Per Employee | 1.20M |
| Profits Per Employee | 219,623 |
| Employee Count | 1,426 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.35 |
Taxes
In the past 12 months, HKG:1061 has paid 68.51 million in taxes.
| Income Tax | 68.51M |
| Effective Tax Rate | 17.95% |
Stock Price Statistics
The stock price has increased by +68.44% in the last 52 weeks. The beta is -0.12, so HKG:1061's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | +68.44% |
| 50-Day Moving Average | 4.06 |
| 200-Day Moving Average | 4.69 |
| Relative Strength Index (RSI) | 61.59 |
| Average Volume (20 Days) | 428,800 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1061 had revenue of HKD 1.72 billion and earned 313.18 million in profits. Earnings per share was 0.55.
| Revenue | 1.72B |
| Gross Profit | 1.54B |
| Operating Income | 388.32M |
| Pretax Income | 381.69M |
| Net Income | 313.18M |
| EBITDA | 433.27M |
| EBIT | 388.32M |
| Earnings Per Share (EPS) | 0.55 |
Balance Sheet
The company has 642.92 million in cash and 291.25 million in debt, with a net cash position of 351.68 million or 0.62 per share.
| Cash & Cash Equivalents | 642.92M |
| Total Debt | 291.25M |
| Net Cash | 351.68M |
| Net Cash Per Share | 0.62 |
| Equity (Book Value) | 2.27B |
| Book Value Per Share | 4.01 |
| Working Capital | 684.04M |
Cash Flow
In the last 12 months, operating cash flow was 359.29 million and capital expenditures -105.83 million, giving a free cash flow of 253.46 million.
| Operating Cash Flow | 359.29M |
| Capital Expenditures | -105.83M |
| Free Cash Flow | 253.46M |
| FCF Per Share | 0.45 |
Margins
Gross margin is 89.56%, with operating and profit margins of 22.61% and 18.23%.
| Gross Margin | 89.56% |
| Operating Margin | 22.61% |
| Pretax Margin | 22.22% |
| Profit Margin | 18.23% |
| EBITDA Margin | 25.22% |
| EBIT Margin | 22.61% |
| FCF Margin | 14.75% |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 3.17%.
| Dividend Per Share | 0.14 |
| Dividend Yield | 3.17% |
| Dividend Growth (YoY) | 23.81% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 21.73% |
| Buyback Yield | 4.11% |
| Shareholder Yield | 7.28% |
| Earnings Yield | 12.47% |
| FCF Yield | 10.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1061 has an Altman Z-Score of 3.31 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.31 |
| Piotroski F-Score | 5 |